MacroGenics
MGNX
#8794
Rank
C$0.33 B
Marketcap
C$5.33
Share price
5.35%
Change (1 day)
125.28%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): C-$0.77

According to MacroGenics's latest financial reports the company's current EPS (TTM) is C-$0.81. In 2025 the company made an earnings per share (EPS) of C-$1.68 a decrease over its 2024 EPS that were of C-$1.53.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.77-54.48%
2025C-$1.6810.28%
2024C-$1.53613.33%
2023C-$0.21-92.31%
2022C-$2.78-42.14%
2021C-$4.8036.44%
2020C-$3.52-21.84%
2019C-$4.50-24.58%
2018C-$5.97675.93%
2017C-$0.77-68.05%
2016C-$2.41168.25%
2015C-$0.90-55%
2014C-$2.003400%
2013C-$0.05702-108.68%
2012C$0.6624.49%
2011C$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.08-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.60-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$23.12-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$3.71 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.80-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C-$3.09 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA